Rational approaches to immune regulation.

Area of Science:

• Immunology
• Vaccinology
• Microbial Pathogenesis

Background:

• Understanding protein immunogenicity is crucial for vaccine development.
• Enhancing immune responses can lead to more effective vaccines against viral diseases and cancers.
• Listeria monocytogenes is an intracellular bacterium that can be engineered as a vaccine vector.

Purpose of the Study:

• To investigate methods for modulating protein immunogenicity in vivo.
• To develop novel vaccine strategies targeting viral diseases (e.g., HIV) and various cancers (breast, ovarian, cervical, B cell lymphomas).
• To utilize Listeria monocytogenes as a live vector for antigen delivery and immune stimulation.

Main Methods:

• Engineering Listeria monocytogenes to express specific antigens.
• Utilizing the intracellular lifestyle of Listeria monocytogenes to target the major histocompatibility complex (MHC) class I pathway.
• Generating authentic cytotoxic T lymphocytes (CTL) epitopes through antigen processing.
• Developing nonliving vaccine vectors for tumor antigens.

Main Results:

• Listeria monocytogenes effectively delivers antigens to the MHC class I pathway.
• The approach generates authentic CTL epitopes, crucial for anti-tumor and anti-viral immunity.
• Development of both live bacterial vectors and nonliving vectors for tumor immunotherapy.

Conclusions:

• Listeria monocytogenes serves as a potent vaccine vector for inducing CTL responses.
• This strategy holds promise for creating advanced vaccines against infectious diseases and cancers.
• Further development of nonliving vectors complements the live-vector approach for tumor immunotherapy.